Non–ST-Segment Elevation Myocardial Infarction

Anticoagulation for ST-segment elevation myocardial infarction.

Adjunctive anticoagulant therapy reduces the risk of recurrent infarction and death in patients with STsegment elevation myocardial infarction (STEMI) receiving fibrinolytic therapy.1–5 Unfractionated heparin (UFH), the first anticoagulant evaluated for this indication,1 continues to be used because of its predominantly nonrenal clearance, short half-life, reversibility, and the familiarity of ...

False Positive ST-Segment Elevation Myocardial Infarction

Acute ST-segment elevation myocardial infarction (STEMI) is a serious disease in clinical practice. The rapid and accurate diagnosis of this critical illness can lead to prompt reperfusion, and it enables the reduction of cardiac ischemic damage and results in improved subsequent outcomes. The shorter the time to reperfusion, the greater the benefits. The American College of Cardiology/American...

ST-Segment Elevation in Acute Myocardial Infarction

Four hundred and four patients who were admitted to the hospital with their first myocardial infarction within 24 hours of the onset of symptoms were studied. In 315 patients the ECG findings in 12 standards leads (I, II, aVF, aVR, aVL, V,-V6) showed the infarction to be in the anterior wall, the inferior wall, or in multiple areas. The patients in each of these three categories were further su...

Myocardial Hemorrhage After Acute Reperfused ST-Segment–Elevation Myocardial Infarction

Imaging of Myocardial Inflammation Post ST-Segment Elevation Myocardial Infarction

The treatment of myocardial infarction (MI) has focused heavily on early reperfusion of the infarct-related artery. However, the inflammatory processes in the infarct that occur shortly after MI and govern wound healing in the heart have not been targeted therapeutically. Perhaps this has resulted from our inability to visualize these processes. In contrast to coronary angiography, which has cl...